Genital warts and other HPV infections: Established and novel therapies
Abstract Wart therapies involve methods of targeted lesion destruction, as well as selective immunologic modification. While there are several therapeutic options, no treatment has been proven to be superior in terms of clinical clearance or recurrence. Controlled trials comparing treatments are cur...
Gespeichert in:
| Veröffentlicht in: | Clinics in dermatology 2014-03, Vol.32 (2), p.299-306 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 306 |
|---|---|
| container_issue | 2 |
| container_start_page | 299 |
| container_title | Clinics in dermatology |
| container_volume | 32 |
| creator | Fathi, Ramin, MD Tsoukas, Maria M., MD, PhD |
| description | Abstract Wart therapies involve methods of targeted lesion destruction, as well as selective immunologic modification. While there are several therapeutic options, no treatment has been proven to be superior in terms of clinical clearance or recurrence. Controlled trials comparing treatments are currently lacking. Many factors are used in the selection of treatment. Variables that should be taken into account include but are not limited to the morphology of the lesions such as thickness and size, quantity, anatomic location, human papilloma virus (HPV) classification, immunocompromized or immune competent status, as well as the preferences of the patient and the provider, cost and availability. No current treatment completely eradicates the human papillomavirus virus. The availability of vaccinations against HPV infection is contributing to the decreasing incidence of this disease. This contribution highlights conventional therapies, off-label treatment strategies including combination therapies, and prophylaxis for condylomata acuminata. |
| doi_str_mv | 10.1016/j.clindermatol.2013.08.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1501838665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0738081X13001648</els_id><sourcerecordid>1501838665</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-10e037a9b8b7bd8f6a9baa5c403dc32f7a3ebd0008139b5b8f65c3c50d00b4143</originalsourceid><addsrcrecordid>eNqNkdFqFDEUhoNY7Nr6CjJ45c2M52wmM9leCFLrVigoaMW7kEnO0KzZZE1mK317M90qxSuvEsKX_0--w9grhAYBuzebxngXLKWtnqJvloC8AdkAtk_YAmW_qhE5PmUL6LmsQeL3Y_Y85w0AtNDBM3a8bIVYia5fsPWagpu0r37pNOVKB1vF6YZSdfn5W-XCSGZyMeSz6iJPevAu35C9p0K8JV_NqN45yqfsaNQ-04uH9YRdf7j4en5ZX31afzx_d1Ub3supRiDgvV4NcugHK8eubLUWpgVuDV-OveY02PJQiXw1iKEQwnAjoJwNLbb8hL0-5O5S_LmnPKmty4a814HiPisUgJLLrhMFPTugJsWcE41ql9xWpzuFoGaRaqMei1SzSAVSwX3Py4ee_bAl-_fqH3MFeH8AqPz21lFS2TgKhqxLRZqy0f1fz9t_YmbUGe1_0B3lTdynUHwqVHmpQH2ZRzpPFDmU5Fby3yqpoEE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1501838665</pqid></control><display><type>article</type><title>Genital warts and other HPV infections: Established and novel therapies</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fathi, Ramin, MD ; Tsoukas, Maria M., MD, PhD</creator><creatorcontrib>Fathi, Ramin, MD ; Tsoukas, Maria M., MD, PhD</creatorcontrib><description>Abstract Wart therapies involve methods of targeted lesion destruction, as well as selective immunologic modification. While there are several therapeutic options, no treatment has been proven to be superior in terms of clinical clearance or recurrence. Controlled trials comparing treatments are currently lacking. Many factors are used in the selection of treatment. Variables that should be taken into account include but are not limited to the morphology of the lesions such as thickness and size, quantity, anatomic location, human papilloma virus (HPV) classification, immunocompromized or immune competent status, as well as the preferences of the patient and the provider, cost and availability. No current treatment completely eradicates the human papillomavirus virus. The availability of vaccinations against HPV infection is contributing to the decreasing incidence of this disease. This contribution highlights conventional therapies, off-label treatment strategies including combination therapies, and prophylaxis for condylomata acuminata.</description><identifier>ISSN: 0738-081X</identifier><identifier>EISSN: 1879-1131</identifier><identifier>DOI: 10.1016/j.clindermatol.2013.08.014</identifier><identifier>PMID: 24559567</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Administration, Topical ; Alphapapillomavirus - genetics ; Antineoplastic Agents - administration & dosage ; Antiviral Agents - administration & dosage ; Antiviral Agents - therapeutic use ; Caustics - therapeutic use ; Condylomata Acuminata - therapy ; Condylomata Acuminata - virology ; Cryotherapy ; Dermatology ; Genotype ; Humans ; Injections, Intralesional ; Laser Therapy ; Photochemotherapy ; Viral Proteins - genetics</subject><ispartof>Clinics in dermatology, 2014-03, Vol.32 (2), p.299-306</ispartof><rights>2014</rights><rights>2014.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c378t-10e037a9b8b7bd8f6a9baa5c403dc32f7a3ebd0008139b5b8f65c3c50d00b4143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0738081X13001648$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24559567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fathi, Ramin, MD</creatorcontrib><creatorcontrib>Tsoukas, Maria M., MD, PhD</creatorcontrib><title>Genital warts and other HPV infections: Established and novel therapies</title><title>Clinics in dermatology</title><addtitle>Clin Dermatol</addtitle><description>Abstract Wart therapies involve methods of targeted lesion destruction, as well as selective immunologic modification. While there are several therapeutic options, no treatment has been proven to be superior in terms of clinical clearance or recurrence. Controlled trials comparing treatments are currently lacking. Many factors are used in the selection of treatment. Variables that should be taken into account include but are not limited to the morphology of the lesions such as thickness and size, quantity, anatomic location, human papilloma virus (HPV) classification, immunocompromized or immune competent status, as well as the preferences of the patient and the provider, cost and availability. No current treatment completely eradicates the human papillomavirus virus. The availability of vaccinations against HPV infection is contributing to the decreasing incidence of this disease. This contribution highlights conventional therapies, off-label treatment strategies including combination therapies, and prophylaxis for condylomata acuminata.</description><subject>Administration, Topical</subject><subject>Alphapapillomavirus - genetics</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Antiviral Agents - administration & dosage</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Caustics - therapeutic use</subject><subject>Condylomata Acuminata - therapy</subject><subject>Condylomata Acuminata - virology</subject><subject>Cryotherapy</subject><subject>Dermatology</subject><subject>Genotype</subject><subject>Humans</subject><subject>Injections, Intralesional</subject><subject>Laser Therapy</subject><subject>Photochemotherapy</subject><subject>Viral Proteins - genetics</subject><issn>0738-081X</issn><issn>1879-1131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkdFqFDEUhoNY7Nr6CjJ45c2M52wmM9leCFLrVigoaMW7kEnO0KzZZE1mK317M90qxSuvEsKX_0--w9grhAYBuzebxngXLKWtnqJvloC8AdkAtk_YAmW_qhE5PmUL6LmsQeL3Y_Y85w0AtNDBM3a8bIVYia5fsPWagpu0r37pNOVKB1vF6YZSdfn5W-XCSGZyMeSz6iJPevAu35C9p0K8JV_NqN45yqfsaNQ-04uH9YRdf7j4en5ZX31afzx_d1Ub3supRiDgvV4NcugHK8eubLUWpgVuDV-OveY02PJQiXw1iKEQwnAjoJwNLbb8hL0-5O5S_LmnPKmty4a814HiPisUgJLLrhMFPTugJsWcE41ql9xWpzuFoGaRaqMei1SzSAVSwX3Py4ee_bAl-_fqH3MFeH8AqPz21lFS2TgKhqxLRZqy0f1fz9t_YmbUGe1_0B3lTdynUHwqVHmpQH2ZRzpPFDmU5Fby3yqpoEE</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Fathi, Ramin, MD</creator><creator>Tsoukas, Maria M., MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140301</creationdate><title>Genital warts and other HPV infections: Established and novel therapies</title><author>Fathi, Ramin, MD ; Tsoukas, Maria M., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-10e037a9b8b7bd8f6a9baa5c403dc32f7a3ebd0008139b5b8f65c3c50d00b4143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Administration, Topical</topic><topic>Alphapapillomavirus - genetics</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Antiviral Agents - administration & dosage</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Caustics - therapeutic use</topic><topic>Condylomata Acuminata - therapy</topic><topic>Condylomata Acuminata - virology</topic><topic>Cryotherapy</topic><topic>Dermatology</topic><topic>Genotype</topic><topic>Humans</topic><topic>Injections, Intralesional</topic><topic>Laser Therapy</topic><topic>Photochemotherapy</topic><topic>Viral Proteins - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fathi, Ramin, MD</creatorcontrib><creatorcontrib>Tsoukas, Maria M., MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinics in dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fathi, Ramin, MD</au><au>Tsoukas, Maria M., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genital warts and other HPV infections: Established and novel therapies</atitle><jtitle>Clinics in dermatology</jtitle><addtitle>Clin Dermatol</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>32</volume><issue>2</issue><spage>299</spage><epage>306</epage><pages>299-306</pages><issn>0738-081X</issn><eissn>1879-1131</eissn><abstract>Abstract Wart therapies involve methods of targeted lesion destruction, as well as selective immunologic modification. While there are several therapeutic options, no treatment has been proven to be superior in terms of clinical clearance or recurrence. Controlled trials comparing treatments are currently lacking. Many factors are used in the selection of treatment. Variables that should be taken into account include but are not limited to the morphology of the lesions such as thickness and size, quantity, anatomic location, human papilloma virus (HPV) classification, immunocompromized or immune competent status, as well as the preferences of the patient and the provider, cost and availability. No current treatment completely eradicates the human papillomavirus virus. The availability of vaccinations against HPV infection is contributing to the decreasing incidence of this disease. This contribution highlights conventional therapies, off-label treatment strategies including combination therapies, and prophylaxis for condylomata acuminata.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24559567</pmid><doi>10.1016/j.clindermatol.2013.08.014</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0738-081X |
| ispartof | Clinics in dermatology, 2014-03, Vol.32 (2), p.299-306 |
| issn | 0738-081X 1879-1131 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1501838665 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Administration, Topical Alphapapillomavirus - genetics Antineoplastic Agents - administration & dosage Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use Caustics - therapeutic use Condylomata Acuminata - therapy Condylomata Acuminata - virology Cryotherapy Dermatology Genotype Humans Injections, Intralesional Laser Therapy Photochemotherapy Viral Proteins - genetics |
| title | Genital warts and other HPV infections: Established and novel therapies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A30%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genital%20warts%20and%20other%20HPV%20infections:%20Established%20and%20novel%20therapies&rft.jtitle=Clinics%20in%20dermatology&rft.au=Fathi,%20Ramin,%20MD&rft.date=2014-03-01&rft.volume=32&rft.issue=2&rft.spage=299&rft.epage=306&rft.pages=299-306&rft.issn=0738-081X&rft.eissn=1879-1131&rft_id=info:doi/10.1016/j.clindermatol.2013.08.014&rft_dat=%3Cproquest_cross%3E1501838665%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1501838665&rft_id=info:pmid/24559567&rft_els_id=1_s2_0_S0738081X13001648&rfr_iscdi=true |